Aranesp Contracts Revised: 50% Share Of ESA Purchases Qualifies Clinics For Best Discount
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen will restructure its previously bundled oncology portfolio contract for Aranesp, Neulasta and Neupogen into separate product contracts.
You may also be interested in...
Pfizer Protonix Settlement May Deter Price Bundling
$784.6m fine will resolve claims that Wyeth subsidiary paid hospitals steep discounts if they purchased both oral and IV Protonix while reporting higher prices to the government.
Sanofi’s Bundled Pediatric Vaccine Contracts Challenged In Antitrust Suit
A class action complaint alleges that Sanofi’s meningococcal vaccine pricing contracts deter physician buying groups from purchasing Novartis’s competing vaccine. The American Antitrust Institute seeks FTC review of these bundled discounts.
Bundling of Wyeth Protonix Sales to Hospitals Tied to Medicaid Fraud, DoJ Says
A whistleblower suit against Wyeth appears to be the first case alleging that a firm's bundling contracts resulted in Medicaid fraud